Pantoprazole Crescent Pharma (Pantoprazole Sodium Sesquihydrate)

Pantoprazole, the active ingredient in Pantoprazole Crescent Pharma, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is prescribed for conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, and Zollinger‑Ellison syndrome in adult patients.

GNH USA supplies Pantoprazole Crescent Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable global distribution.

Pantoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by decreasing stomach acid. Erosive oesophagitis: promotes healing of acid‑induced esophageal lesions. Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors. NSAID‑induced gastric ulcer: aids ulcer healing and prevents recurrence when used with protective therapy.

Pantoprazole may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate pain in the head. - Diarrhea: loose stools. - Nausea: feeling of sickness. - Abdominal pain: discomfort in the stomach area. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Low serum magnesium (hypomagnesemia): muscle cramps, irregular heartbeat. - Liver enzyme elevation: increased ALT/AST indicating hepatic stress.

When prescribing Pantoprazole, clinicians should consider several safety measures to minimize risk. - Renal function assessment: adjust use in severe renal impairment. - Hepatic impairment caution: monitor liver enzymes in patients with liver disease. - Magnesium monitoring: check serum magnesium during prolonged therapy. - Long‑term use evaluation: limit duration unless clearly indicated. - Drug interaction review: assess concurrent medications that may affect acid levels. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Pantoprazole can affect the pharmacokinetics of other medicines; interactions are classified by clinical significance.

Major Interactions (Avoid): - Atazanavir (HIV protease inhibitor): reduced absorption leading to therapeutic failure. - Nelfinavir (HIV protease inhibitor): markedly decreased plasma concentrations. - Rilpivirine (HIV NNRTI): absorption impaired, loss of antiviral effect.

Moderate Interactions (Monitor Closely): - Clopidogrel: reduced antiplatelet activity. - Methotrexate (high dose): increased serum levels, risk of toxicity. - Digoxin: possible increase in serum concentration. - Iron salts: decreased iron absorption, consider separation of dosing.